Alar Pharmaceuticals Inc. (6785.TWO)

TWD 122.0

(1.67%)

Net Income Summary of Alar Pharmaceuticals Inc.

  • Alar Pharmaceuticals Inc.'s latest annual net income in 2023 was 382.61 Million TWD , up 2025.5% from previous year.
  • Alar Pharmaceuticals Inc.'s latest quarterly net income in 2024 Q2 was -3.54 Million TWD , down -129.4% from previous quarter.
  • Alar Pharmaceuticals Inc. reported an annual net income of -19.87 Million TWD in 2022, up 69.06% from previous year.
  • Alar Pharmaceuticals Inc. reported an annual net income of -64.23 Million TWD in 2021, up 55.02% from previous year.
  • Alar Pharmaceuticals Inc. reported a quarterly net income of 12.04 Million TWD for 2024 Q1, down -97.04% from previous quarter.
  • Alar Pharmaceuticals Inc. reported a quarterly net income of 407.43 Million TWD for 2023 Q4, up 23423.85% from previous quarter.

Annual Net Income Chart of Alar Pharmaceuticals Inc. (2023 - 2019)

Historical Annual Net Income of Alar Pharmaceuticals Inc. (2023 - 2019)

Year Net Income Net Income Growth
2023 382.61 Million TWD 2025.5%
2022 -19.87 Million TWD 69.06%
2021 -64.23 Million TWD 55.02%
2020 -142.79 Million TWD -110.09%
2019 -67.97 Million TWD 0.0%

Peer Net Income Comparison of Alar Pharmaceuticals Inc.

Name Net Income Net Income Difference
Allied Biotech Corporation 97.41 Million TWD -292.781%
GeneFerm Biotechnology Co., Ltd. 124.62 Million TWD -207.024%
Easywell Biomedicals, Inc. -144.81 Million TWD 364.205%
TTY Biopharm Company Limited 1.12 Billion TWD 66.095%
Synmosa Biopharma Corporation 594.83 Million TWD 35.677%
Orient EuroPharma Co., Ltd. 143.94 Million TWD -165.811%
Center Laboratories, Inc. -995.42 Million TWD 138.438%
Tien Liang BioTech Co., Ltd. 17.73 Million TWD -2057.771%
Orient Pharma Co., Ltd. 22.28 Million TWD -1616.691%
InnoPharmax Inc. -70.83 Million TWD 640.182%
Johnson Chemical Pharmaceutical Works Co., Ltd. 79.7 Million TWD -380.07%
Excelsior Biopharma Inc. -91.01 Million TWD 520.406%
DV Biomed Co., Ltd. 162.91 Million TWD -134.863%
Foresee Pharmaceuticals Co., Ltd. -1.03 Billion TWD 136.921%
Handa Pharmaceuticals, Inc. 726.88 Million TWD 47.362%
UniPharma Co., Ltd. -21.81 Million TWD 1854.073%
Anxo Pharmaceutical Co., Ltd. 21.86 Million TWD -1650.222%
Winston Medical Supply Co., Ltd. 158.75 Million TWD -141.01%
Mercury Biopharmaceutical Corporation -43.81 Million TWD 973.234%
Bioray Biotech Co., Ltd -11.55 Million TWD 3410.113%
TSH Biopharm Corporation Limited 61.98 Million TWD -517.232%